D.B. Root & Company LLC Sells 187 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

D.B. Root & Company LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 837 shares of the medical equipment provider’s stock after selling 187 shares during the period. D.B. Root & Company LLC’s holdings in Intuitive Surgical were worth $411,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in ISRG. Norden Group LLC boosted its holdings in shares of Intuitive Surgical by 32.4% in the 1st quarter. Norden Group LLC now owns 957 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 234 shares in the last quarter. Csenge Advisory Group boosted its holdings in shares of Intuitive Surgical by 16.4% during the 1st quarter. Csenge Advisory Group now owns 1,229 shares of the medical equipment provider’s stock valued at $490,000 after acquiring an additional 173 shares in the last quarter. Advisory Alpha LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter valued at $414,000. Empirical Finance LLC boosted its holdings in shares of Intuitive Surgical by 3.5% during the 1st quarter. Empirical Finance LLC now owns 12,648 shares of the medical equipment provider’s stock valued at $5,048,000 after acquiring an additional 433 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Intuitive Surgical by 16.1% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 42,804 shares of the medical equipment provider’s stock valued at $17,083,000 after acquiring an additional 5,941 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $515.55 on Thursday. The company has a market capitalization of $183.63 billion, a P/E ratio of 82.89, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $269.49 and a 52-week high of $525.00. The business has a 50-day simple moving average of $492.30 and a two-hundred day simple moving average of $450.05.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,558,968.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 68,246 shares of company stock worth $33,839,308 in the last 90 days. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Barclays raised their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.